NRX Nurexone Biologic Inc

0.63

0.08 (14.55%)

31 Jan 2025 - Closed

Delayed by 15 minutes

Share Name	Share Symbol	Market	Type
Nurexone Biologic Inc	TSXV:NRX	TSX Venture	Common Stock

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	0.08	14.55%	0.63	0.63	0.64	0.63	0.56	0.56	63,025	20:58:11

Cancellation of Listing

16/04/2003 11:48am

UK Regulatory

RNS Number:1018K
NRX Global Corporation 
16 April 2003

NRX Global Corp. ("NRX" or "the Company")



16th April 2003





Further to its announcement of 5 March 2003 NRX announces that it has requested
the London Stock Exchange to cancel admission of its common shares to the
Alternative Investment Market ("AIM") with effect from the close of business on
20 May 2003. The Company has determined that, at this time, it is in the best
interests of the Company and its shareholders that the AIM admission be
cancelled.



NRX will endeavour to facilitate trading in the Company's common shares both
prior and subsequent to the cancellation of the AIM admission.



Enquiries: Paul Gray, Chief Executive Officer - 001 416 368 4567






                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

MSCGUUQCCUPWGUQ